NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
Voltar para busca
Dado oficial do USPTO
ACCRETAMAB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
11/07/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
06/07/2021
Data de registro
11/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/07/2023
Última transação
11/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
MESSICK, TABITHA LEE
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Kyowa Kirin Co., Ltd.
Representantes
Kaushal Odedra ODEDRA LAW OFFICE, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Host cells for medical or clinical use; cells for medical usecells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; cells for medical usetransfected cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticalscentral nervous system depressantspreparations for ophthalmic useanti-histaminicscardiotonicsarrhythmia treating agentsdiureticshypotensors being pharmaceutical products for treatment of blood pressureprophylactic for the treatment of asthmaantitussives and expectorantsstomachics and digestives for pharmaceutical purposesantacidshormones in the nature of pituitary hormones for the treatment of infertilitythyroid hormones for the treatment of hyperthyroidismanabolic hormones for the treatment of aplastic anemia and osteoporosis; pharmaceuticalscorticosteroids for treatment of hypopituitarismof congenital adrenal hyperplasiaof rheumatoid arthritisof rheumatic feverof crohn's diseaseof chronic active hepatitis; pharmaceuticalsestrogen preparations and progesterone used as combined oral contraceptivesurinary antisepticsanalgesicsanti-itching agents; pharmaceuticalscataplasms being medical plasters for the treatment of bruiseslumbago and stiff shoulder; pharmaceuticalspharmaceutical preparations used to treat hair disordersvitamin preparationsfood enriching agents in the nature of vitamins for treating vitamin deficienciesanti-coagulantsenzyme preparations for medical purposes for control of malabsorption and diarrheaanti-cancer preparationsanti-sarcoma preparationsantibiotics and their preparations for the treatment of infectious diseasesantituberculotic agentsinfluenza vaccinesdiphtheria vaccinestetanus vaccinesgas gangrene vaccinesJapanese encephalitis vaccinesin vitro tetrodotoxines for medical useantiprotozoals for the treatment of trichomoniasis and dermatophytosisanthelmintics for the treatment of threadworm and toxoplasmaosisnaturally occurring drugs delivery agents in the form of capsulesliquidspowderspatches for treating peptic ulcerscharred drugs delivery agents in the form of capsulesliquidspowderspatches for treating peptic ulcersmoxa in the nature of cone or stick made of ground mugwort leaves for treating peptic ulcers; pharmaceuticalsveterinary drugs for the treatment of distemper in dogsdistomatosis in dogscoccidian in chickensdysentery in pigs; pharmaceuticalsgermination controllers and plant rearing agents in the nature of herbicidesfungicidesinsecticidesbactericides and rodenticides for domestic and agricultural use; pharmaceuticalsantisepticspharmaceutical drugs in the nature of drug delivery agents in the form of coatings for tablets for the treatment of arteriosclerosisoncostatic drugs in the nature of pharmaceutical products for the treatment for cancermultienzyme digestants for pharmaceutical in vivo useantifungal antibiotics for treating trichomoniasis and dermatophytosisdrugs in the nature of pharmaceutical products for the prevention and treatment of parkinsonismminor tranquilizersanti anxiety agents; pharmaceuticalsmedicinal preparations for the treatment of the central nervous systemthe respiratory tract and the cardiovascular system; pharmaceuticalsanti-bacterial preparations in the nature of antibacterial substances for medical purposesmonolithic preparations in the nature of substances for medical purposesmedicinal preparations for the treatment of peptic ulcersanti-inflammatory preparationsanalgesic preparationscephalosporincocarboxylase preparationsglutathione preparations in the nature of radioactive substances and nutritive substances for microorganisms for medical purposespharmaceutical preparations for improving the metabolism and the peripheral circulationblood plasma in the nature of plasma substitutes and extracorporeal circulation flow improvement preparationsdiuretic and anti-hypertensive preparationsin vitro diagnostic reagents for medical usein vitro extra corporeal diagnostic reagents for medical usein vitro x-ray contrast agents for medical usein vitro diagnostic media for medical usepharmaceutical preparations for the treatment of insomnia and other sleep related diseases; all the foregoing pharmaceuticals and vaccines comprising monoclonal antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/04/2023
PUBO
PUBLISHED FOR OPPOSITION
25/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
17/03/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/08/2022
GNRT
NON-FINAL ACTION E-MAILED
31/08/2022
CNRT
NON-FINAL ACTION WRITTEN
31/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/02/2022
GNRT
NON-FINAL ACTION E-MAILED
16/02/2022
CNRT
NON-FINAL ACTION WRITTEN
16/02/2022
DOCK
ASSIGNED TO EXAMINER
09/02/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
20/09/2021
ALIE
ASSIGNED TO LIE
17/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/09/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/07/2021
NWAP
NEW APPLICATION ENTERED
09/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACCRETAMAB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.